FIELD: medicine. SUBSTANCE: method involves administering two therapeutic agents one of which is N-methyl-D-aspartate antagonist selective relative to forebrain and an agent exciting biofeedback between ventral lateral thalamus nucleus and cerebral cortex. The amount of each of the mentioned agents is enough for achieving synergy effect. The agents are optionally administered separately or united in a pharmaceutical composition. EFFECT: enhanced effectiveness of treatment. 42 cl
Authors
Dates
2001-11-27—Published
1995-05-26—Filed